CPT1A rs80356801: Understanding This Genetic Variant
The rs80356801 variant is a specific genetic change located within the CPT1A gene. It is clinically associated with carnitine palmitoyltransferase I deficiency, a rare metabolic disorder that affects how the body processes fats for energy.
What each genotype means
Typical CPT1A genotype
This genotype represents the common, non-variant form of the CPT1A gene at this location. It is associated with normal production of the carnitine palmitoyltransferase 1A enzyme, which is essential for converting fats into energy in the liver.
This is the most common genotype observed in the general population.
What is the rs80356801 Variant?
The rs80356801 variant is a specific alteration in the DNA sequence of the CPT1A gene, which is located on chromosome 11. In genetic databases, this variant is often identified as a deletion, specifically a loss of a guanine nucleotide. Because genes are the blueprints for proteins, changes in the DNA sequence can potentially alter the structure or function of the resulting protein. This particular variant is categorized in clinical databases as pathogenic, meaning it is linked to a known medical condition. It is important to note that genetic variants are common in the human population, and their presence does not automatically imply a health crisis. However, because this variant is associated with a specific metabolic disorder, it is frequently studied in the context of newborn screening and clinical genetics to help identify individuals who may require specialized dietary management or medical monitoring.
The Role of the CPT1A Gene
The CPT1A gene provides the instructions for the body to produce an enzyme called carnitine palmitoyltransferase 1A. This enzyme is primarily active in the liver and plays a critical role in the process of fatty acid oxidation. Essentially, this enzyme acts as a gatekeeper, helping to transport long-chain fatty acids into the mitochondria, which are the powerhouses of the cell. Once inside, these fats are broken down and converted into energy. This process is especially vital during periods of fasting or when the body needs to rely on fat stores rather than glucose for fuel. When the CPT1A enzyme is not functioning correctly due to a genetic variant, the body may struggle to produce enough energy from fats, which can lead to the accumulation of certain substances and a deficiency in the energy needed for normal metabolic function.
Research and Clinical Associations
Research into rs80356801 has primarily focused on its role in carnitine palmitoyltransferase I deficiency. This is an inherited metabolic condition that is typically passed down in an autosomal recessive manner, meaning an individual usually needs to inherit two copies of the variant—one from each parent—to be at risk for the condition. Clinical evidence, such as that found in the ClinVar database, classifies this variant as pathogenic because it disrupts the normal production or function of the CPT1A enzyme. The primary clinical concern associated with this deficiency is the body's inability to maintain energy levels during fasting, which can lead to symptoms like hypoketotic hypoglycemia. While this variant is a known cause of the disorder, the severity of symptoms can vary significantly between individuals. It is essential to consult with a medical geneticist or a metabolic specialist to understand the specific implications of this variant in a clinical context.
Population Frequency
The rs80356801 variant is considered rare in the general global population. Unlike some other variants in the CPT1A gene that have reached high frequencies in specific Arctic populations due to historical selective pressures, rs80356801 is not widespread. Because it is rare, most individuals will not carry this specific variant. When it is identified, it is often through targeted clinical testing or newborn screening programs designed to detect metabolic disorders. The rarity of this variant means that large-scale population studies often report very low allele frequencies, making it a focus of clinical diagnostics rather than general population health screening.
Managing Genetic Information
If you have received information about the rs80356801 variant, it is important to approach it with the guidance of a healthcare professional. This information is not a diagnosis, and the presence of a variant does not necessarily mean you or a family member will experience health issues. Genetic testing results should always be interpreted by a qualified clinician or genetic counselor who can consider your full medical history and family background. You cannot 'fix' or 'change' a genetic variant, but understanding your genetic profile can help you and your doctor make informed decisions about your health. If you are concerned about metabolic health or have a family history of related conditions, discuss these findings with your primary care physician or a specialist. They can provide appropriate testing, monitoring, or dietary guidance if necessary. Never make changes to your diet or medical regimen based solely on genetic data without professional oversight.
How common is this variant?
The rs80356801 variant is rare in the general population. It is not a common polymorphism and is typically identified in clinical settings rather than general population screening.
Frequently asked questions
What is CPT1A deficiency?
CPT1A deficiency is a rare inherited metabolic disorder that prevents the body from effectively converting long-chain fatty acids into energy, especially during fasting.
Is rs80356801 the same as the P479L variant?
No, rs80356801 is a distinct variant from the P479L (rs80356779) variant. While both are in the CPT1A gene, they are different genetic changes with different clinical and population profiles.
Should I be worried if I have this variant?
Genetic variants are common, and having one does not mean you have a disease. You should discuss any genetic findings with a doctor or genetic counselor to understand what they mean for your specific health.
How is CPT1A deficiency diagnosed?
Diagnosis is typically made through newborn screening, blood tests to measure enzyme activity or acylcarnitine levels, and confirmed via genetic testing.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs80356801?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CPT1A
This variant in the CPT1A gene is associated with carnitine palmitoyltransferase I deficiency, affecting the body's ability to manage metabolic stress during fasting.
This variant is associated with Carnitine palmitoyltransferase I deficiency, a metabolic disorder.